Rate of recurrence after discontinuing anticoagulation in patients with venous thromboembolism within 30 days after COVID-19 vaccine

RIETE Investigators; Andris Skride; Dana Kigitoviča

doi:10.1111/eci.14310

Rate of recurrence after discontinuing anticoagulation in patients with venous thromboembolism within 30 days after COVID-19 vaccine

RIETE Investigators
, Andris Skride (Member of the Working Group)
, Dana Kigitoviča (Member of the Working Group)

Research output: Contribution to journal › Letter › peer-review

1 Citation (Scopus)

Abstract

This study generated evidence to guide anticoagulation in patients with VTE after vaccination for COVID-19. We provided data on the low recurrence rate after cessation of anticoagulant therapy and the findings for this study offer timely insights into the management of a potentially vaccine-related adverse event.

Original language	English
Article number	e14310
Number of pages	7
Journal	European Journal of Clinical Investigation
Volume	54
Issue number	12
DOIs	https://doi.org/10.1111/eci.14310
Publication status	Published - Dec 2024
Externally published	Yes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Keywords*

anticoagulation therapy,
COVID-19
COVID-19 vaccines
pulmonary embolism
venous thromboembolism
anticoagulation therapy

Field of Science*

3.2 Clinical medicine

Publication Type*

1.1. Scientific article indexed in Web of Science and/or Scopus database

Access to Document

10.1111/eci.14310

Cite this

@article{d6d5dadcc2a14cb189d10308822bac74,

title = "Rate of recurrence after discontinuing anticoagulation in patients with venous thromboembolism within 30 days after COVID-19 vaccine",

abstract = "This study generated evidence to guide anticoagulation in patients with VTE after vaccination for COVID-19. We provided data on the low recurrence rate after cessation of anticoagulant therapy and the findings for this study offer timely insights into the management of a potentially vaccine-related adverse event.",

keywords = "anticoagulation therapy,, COVID-19, COVID-19 vaccines, pulmonary embolism, venous thromboembolism, anticoagulation therapy",

author = "Luis Jara-Palomares and Behnood Bikdeli and David Jim{\'e}nez and Alfonso Muriel and Pablo Demelo-Rodr{\'i}guez and Isabelle Mah{\'e} and L{\'o}pez-N{\'u}{\~n}ez, \{Juan Jos{\'e}\} and Megido, \{Joaqu{\'i}n Alfonso\} and \{Fern{\'a}ndez Jim{\'e}nez\}, Bego{\~n}a and Manuel Monreal and \{RIETE Investigators\} and Andris Skride and Dana Kigitovi{\v c}a",

note = "{\textcopyright} 2024 Stichting European Society for Clinical Investigation Journal Foundation. Published by John Wiley \& Sons Ltd.",

year = "2024",

month = dec,

doi = "10.1111/eci.14310",

language = "English",

volume = "54",

journal = "European Journal of Clinical Investigation",

issn = "0014-2972",

publisher = "John Wiley and Sons Inc.",

number = "12",

}

Rate of recurrence after discontinuing anticoagulation in patients with venous thromboembolism within 30 days after COVID-19 vaccine. / RIETE Investigators ; Skride, Andris (Member of the Working Group); Kigitoviča, Dana (Member of the Working Group).
In: European Journal of Clinical Investigation, Vol. 54, No. 12, e14310, 12.2024.

Research output: Contribution to journal › Letter › peer-review

TY - JOUR

T1 - Rate of recurrence after discontinuing anticoagulation in patients with venous thromboembolism within 30 days after COVID-19 vaccine

AU - Jara-Palomares, Luis

AU - Bikdeli, Behnood

AU - Jiménez, David

AU - Muriel, Alfonso

AU - Demelo-Rodríguez, Pablo

AU - Mahé, Isabelle

AU - López-Núñez, Juan José

AU - Megido, Joaquín Alfonso

AU - Fernández Jiménez, Begoña

AU - Monreal, Manuel

AU - RIETE Investigators

A2 - Skride, Andris

A2 - Kigitoviča, Dana

PY - 2024/12

Y1 - 2024/12

N2 - This study generated evidence to guide anticoagulation in patients with VTE after vaccination for COVID-19. We provided data on the low recurrence rate after cessation of anticoagulant therapy and the findings for this study offer timely insights into the management of a potentially vaccine-related adverse event.

AB - This study generated evidence to guide anticoagulation in patients with VTE after vaccination for COVID-19. We provided data on the low recurrence rate after cessation of anticoagulant therapy and the findings for this study offer timely insights into the management of a potentially vaccine-related adverse event.

KW - anticoagulation therapy,

KW - COVID-19

KW - COVID-19 vaccines

KW - pulmonary embolism

KW - venous thromboembolism

KW - anticoagulation therapy

UR - https://www.scopus.com/pages/publications/85203238256

U2 - 10.1111/eci.14310

DO - 10.1111/eci.14310

M3 - Letter

C2 - 39233322

SN - 0014-2972

VL - 54

JO - European Journal of Clinical Investigation

JF - European Journal of Clinical Investigation

IS - 12

M1 - e14310

ER -